Cargando…
Acute effects of acrolein in human volunteers during controlled exposure
Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irrita...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732413/ https://www.ncbi.nlm.nih.gov/pubmed/26635308 http://dx.doi.org/10.3109/08958378.2015.1115567 |
_version_ | 1782412698381713408 |
---|---|
author | Dwivedi, Aishwarya M. Johanson, Gunnar Lorentzen, Johnny C. Palmberg, Lena Sjögren, Bengt Ernstgård, Lena |
author_facet | Dwivedi, Aishwarya M. Johanson, Gunnar Lorentzen, Johnny C. Palmberg, Lena Sjögren, Bengt Ernstgård, Lena |
author_sort | Dwivedi, Aishwarya M. |
collection | PubMed |
description | Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irritation for acrolein. Methods: Nine healthy volunteers of each sex were exposed at six occasions for 2 h at rest to: clean air, 15 ppm ethyl acetate (EA), and 0.05 ppm and 0.1 ppm acrolein with and without EA (15 ppm) to mask the potential influence of odor. Symptoms related to irritation and central nervous system effects were rated on 100-mm Visual Analogue Scales. Results: The ratings of eye irritation were slightly but significantly increased during exposure to acrolein in a dose-dependent manner (p < 0.001, Friedman test) with a median rating of 8 mm (corresponding to “hardly at all”) at the 0.1 ppm condition and with no influence from EA. No significant exposure-related effects were found for pulmonary function, or nasal swelling, nor for markers of inflammation and coagulation in blood (IL-6, C-reactive protein, serum amyloid A, fibrinogen, factor VIII, von Willebrand factor, and Clara cell protein) or induced sputum (cell count, differential cell count, IL-6 and IL-8). Blink frequency recorded by electromyography was increased during exposure to 0.1 ppm acrolein alone but not during any of the other five exposure conditions. Conclusion: Based on subjective ratings, the present study showed minor eye irritation by exposure to 0.1 ppm acrolein. |
format | Online Article Text |
id | pubmed-4732413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-47324132016-02-16 Acute effects of acrolein in human volunteers during controlled exposure Dwivedi, Aishwarya M. Johanson, Gunnar Lorentzen, Johnny C. Palmberg, Lena Sjögren, Bengt Ernstgård, Lena Inhal Toxicol Research Article Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irritation for acrolein. Methods: Nine healthy volunteers of each sex were exposed at six occasions for 2 h at rest to: clean air, 15 ppm ethyl acetate (EA), and 0.05 ppm and 0.1 ppm acrolein with and without EA (15 ppm) to mask the potential influence of odor. Symptoms related to irritation and central nervous system effects were rated on 100-mm Visual Analogue Scales. Results: The ratings of eye irritation were slightly but significantly increased during exposure to acrolein in a dose-dependent manner (p < 0.001, Friedman test) with a median rating of 8 mm (corresponding to “hardly at all”) at the 0.1 ppm condition and with no influence from EA. No significant exposure-related effects were found for pulmonary function, or nasal swelling, nor for markers of inflammation and coagulation in blood (IL-6, C-reactive protein, serum amyloid A, fibrinogen, factor VIII, von Willebrand factor, and Clara cell protein) or induced sputum (cell count, differential cell count, IL-6 and IL-8). Blink frequency recorded by electromyography was increased during exposure to 0.1 ppm acrolein alone but not during any of the other five exposure conditions. Conclusion: Based on subjective ratings, the present study showed minor eye irritation by exposure to 0.1 ppm acrolein. Taylor & Francis 2015-12-06 2015-12-04 /pmc/articles/PMC4732413/ /pubmed/26635308 http://dx.doi.org/10.3109/08958378.2015.1115567 Text en © 2015 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Article Dwivedi, Aishwarya M. Johanson, Gunnar Lorentzen, Johnny C. Palmberg, Lena Sjögren, Bengt Ernstgård, Lena Acute effects of acrolein in human volunteers during controlled exposure |
title | Acute effects of acrolein in human volunteers during controlled exposure |
title_full | Acute effects of acrolein in human volunteers during controlled exposure |
title_fullStr | Acute effects of acrolein in human volunteers during controlled exposure |
title_full_unstemmed | Acute effects of acrolein in human volunteers during controlled exposure |
title_short | Acute effects of acrolein in human volunteers during controlled exposure |
title_sort | acute effects of acrolein in human volunteers during controlled exposure |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732413/ https://www.ncbi.nlm.nih.gov/pubmed/26635308 http://dx.doi.org/10.3109/08958378.2015.1115567 |
work_keys_str_mv | AT dwivediaishwaryam acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure AT johansongunnar acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure AT lorentzenjohnnyc acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure AT palmberglena acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure AT sjogrenbengt acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure AT ernstgardlena acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure |